The DOI matches its Crossref record.
The clinical landscape for AAV gene therapies
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Until now, there have been over 100 clinical trials using wildtype and engineered AAV vectors (6).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [6]
In the citing paper
“Over the past few years, more treatment emergent serious adverse events (TESAEs) have been reported as more patients receive AAV delivery (6), generating serious concerns about AAV immunogenicity and toxicity.”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [6]
In the citing paper
“Preexisting and induced host immune responses to rAAV vectors have indeed emerged as a major limitation, undermining efficacy or even leading to a hold of some clinical trials [1][2][3].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [1]
Citations
Cites
Still being checked.
Cited by
Therapeutic in vivo delivery of gene editing agents
Raguram, A., Banskota, S., & Liu, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.03.045 · Cited by 522
Gene therapy advances: A meta-analysis of AAV usage in clinical settings
Au, H. K. E., Isalan, M., & Mielcarek, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.809118 · Cited by 284
Viral vector‐based gene therapies in the clinic
Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10258 · Cited by 269
Efficient prime editing in mouse brain, liver and heart with dual AAVs
Davis, J. R., Banskota, S., Levy, J. M., Newby, G. A., Wang, X., Anzalone, A. V., Nelson, A. T., Chen, P. J., Hennes, A. D., An, M., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01758-z · Cited by 227
Viral Vector-Based Gene Therapy
Li, X., Le, Y., Zhang, Z., Nian, X., Liu, B., & Yang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097736 · Cited by 200
Metadata
- Authors
- Kuzmin, D. A., Shutova, M. V., Johnston, N. R., Smith, O. P., Fedorin, V. V., Kukushkin, Y. S., van der Loo, J. C. M., & Johnstone, E. C.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Kuzmin, Dmitry A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2021-01-25
- Volume
- 20
- Issue
- 3
- Pages
- 173-174
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W3124760643
- Cited by
- 503
- References
- 0
- Citations by year
- 2026: 53 · 2025: 85 · 2024: 107 · 2023: 111 · 2022: 113 · 2021: 33
- FWCI
- 51.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- adeno-associated virus, gene therapy, clinical trials, adeno-associated virus vectors, gene therapy development
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Humans, Genetic Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The clinical landscape for AAV gene therapies. https://app.cochat.ai/papers/10.1038/d41573-021-00017-7
- The paper
- Kuzmin, D. A., Shutova, M. V., Johnston, N. R., Smith, O. P., Fedorin, V. V., Kukushkin, Y. S., van der Loo, J. C. M., & Johnstone, E. C. (2021). The clinical landscape for AAV gene therapies. Nature Reviews Drug Discovery. https://doi.org/10.1038/d41573-021-00017-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.